(Q42280287)

19 October 2017

title

Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study (English)

1 reference

19 October 2017

0 references

1 reference

1 reference

Carla Treloar

7

0 references

Gregory J Dore

10

object named as

Gregory J Dore

1 reference

19 October 2017

2

Jason Grebely

1 reference

19 October 2017

Maryam Alavi

1

1 reference

19 October 2017

Michelle Micallef

3

1 reference

19 October 2017

Adrian J Dunlop

4

1 reference

19 October 2017

Annie C Balcomb

5

1 reference

19 October 2017

Carolyn A Day

6

1 reference

19 October 2017

Nicky Bath

8

1 reference

19 October 2017

Paul S Haber

9

1 reference

19 October 2017

Enhancing Treatment for Hepatitis C in Opioid Substitution Settings (ETHOS) Study Group

11

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 August 2013

1 reference

Clinical Infectious Diseases

19 October 2017

published in

1 reference

19 October 2017

volume

57 Suppl 2

1 reference

19 October 2017

page(s)

S62-9

1 reference

Global epidemiology of hepatitis C virus infection

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT305

What is killing people with hepatitis C virus infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT305

Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT305

Diagnosis, management, and treatment of hepatitis C: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT305

Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT305

Outcomes of treatment for hepatitis C virus infection by primary care providers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT305

Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer support

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT305

Models of care for the management of hepatitis C virus among people who inject drugs: one size does not fit all.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT305

Successful integration of hepatitis C evaluation and treatment services with methadone maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT305

Integrated internist - addiction medicine - hepatology model for hepatitis C management for individuals on methadone maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT305

Importance of patient, provider, and facility predictors of hepatitis C virus treatment in veterans: a national study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT305

Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT305

Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT305

Predictors of treatment in patients with chronic hepatitis C infection - role of patient versus nonpatient factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT305

Rate and predictors of treatment prescription for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT305

The short-form version of the Depression Anxiety Stress Scales (DASS-21): construct validity and normative data in a large non-clinical sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT305

Development and validation of a brief instrument for routine outcome monitoring in opioid maintenance pharmacotherapy services: the brief treatment outcome measure (BTOM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT305

The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT305

Limited uptake of hepatitis C treatment among injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT305

Hepatitis C virus infection in san francisco’s HIV-infected urban poor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT305

Management of patients with hepatitis C in a community population: diagnosis, discussions, and decisions to treat

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT305

Referral for chronic hepatitis C treatment from a drug dependency treatment setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT305

Polydrug abuse: a review of opioid and benzodiazepine combination use

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT305

Meth/amphetamine use and associated HIV: Implications for global policy and public health

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT305

21 January 2018

Identifiers

DOI

10.1093/CID/CIT305

1 reference

19 October 2017

1 reference